Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement

M. Pigazzi; E. Manara; B. Buldini; V. Beqiri; V. Bisio; C. Tregnago; R. Rondelli; R. Masetti; Putti M. Caterina; F. Fagioli; C. Rizzari; A. Pession; Franco Locatelli; G. Basso

doi:10.3324/haematol.2014.114579

Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement

M. Pigazzi^*
, E. Manara
, B. Buldini
, V. Beqiri
, V. Bisio
, C. Tregnago
, R. Rondelli
, R. Masetti
, Putti M. Caterina
, F. Fagioli
, C. Rizzari
, A. Pession
, Franco Locatelli
, G. Basso

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

no abstract

Lingua originale	Inglese
pagine (da-a)	e99-e101
Rivista	Haematologica
Volume	100
Numero di pubblicazione	3
DOI	https://doi.org/10.3324/haematol.2014.114579
Stato di pubblicazione	Pubblicato - 2015

All Science Journal Classification (ASJC) codes

Ematologia

Keywords

21)
AIEOPt(8
AML
AML1-ETORUNX1-RUNX1T1
CBFB-MYH11
Inv(16)
Molecular MRD
Pediatric
RQ-PCR

Accesso al documento

10.3324/haematol.2014.114579

Altri file e collegamenti

Cita questo

Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., Rondelli, R., Masetti, R., Caterina, P. M., Fagioli, F., Rizzari, C., Pession, A., Locatelli, F., & Basso, G. (2015). Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement. Haematologica, 100(3), e99-e101. https://doi.org/10.3324/haematol.2014.114579

@article{210864044dbe4093914e8f339c7a2876,

title = "Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement",

abstract = "no abstract",

keywords = "21), AIEOPt(8, AML, AML1-ETORUNX1-RUNX1T1, CBFB-MYH11, Inv(16), Molecular MRD, Pediatric, RQ-PCR, 21), AIEOPt(8, AML, AML1-ETORUNX1-RUNX1T1, CBFB-MYH11, Inv(16), Molecular MRD, Pediatric, RQ-PCR",

author = "M. Pigazzi and E. Manara and B. Buldini and V. Beqiri and V. Bisio and C. Tregnago and R. Rondelli and R. Masetti and Caterina, \{Putti M.\} and F. Fagioli and C. Rizzari and A. Pession and Franco Locatelli and G. Basso",

year = "2015",

doi = "10.3324/haematol.2014.114579",

language = "English",

volume = "100",

pages = "e99--e101",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

Pigazzi, M, Manara, E, Buldini, B, Beqiri, V, Bisio, V, Tregnago, C, Rondelli, R, Masetti, R, Caterina, PM, Fagioli, F, Rizzari, C, Pession, A, Locatelli, F & Basso, G 2015, 'Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement', Haematologica, vol. 100, n. 3, pagg. e99-e101. https://doi.org/10.3324/haematol.2014.114579

TY - JOUR

T1 - Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement

AU - Pigazzi, M.

AU - Manara, E.

AU - Buldini, B.

AU - Beqiri, V.

AU - Bisio, V.

AU - Tregnago, C.

AU - Rondelli, R.

AU - Masetti, R.

AU - Caterina, Putti M.

AU - Fagioli, F.

AU - Rizzari, C.

AU - Pession, A.

AU - Locatelli, Franco

AU - Basso, G.

PY - 2015

Y1 - 2015

N2 - no abstract

AB - no abstract

KW - 21)

KW - AIEOPt(8

KW - AML

KW - AML1-ETORUNX1-RUNX1T1

KW - CBFB-MYH11

KW - Inv(16)

KW - Molecular MRD

KW - Pediatric

KW - RQ-PCR

KW - 21)

KW - AIEOPt(8

KW - AML

KW - AML1-ETORUNX1-RUNX1T1

KW - CBFB-MYH11

KW - Inv(16)

KW - Molecular MRD

KW - Pediatric

KW - RQ-PCR

UR - https://publicatt.unicatt.it/handle/10807/229173

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84924690189&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84924690189&origin=inward

U2 - 10.3324/haematol.2014.114579

DO - 10.3324/haematol.2014.114579

M3 - Article

SN - 0390-6078

VL - 100

SP - e99-e101

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo